(Q44345826)

2 December 2017

title

HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity (English)

1 reference

2 December 2017

0 references

1 reference

1

K Ulbrich

0 references

author name string

K Ulbrich

1

1 reference

2 December 2017

T Etrych

2

1 reference

2 December 2017

P Chytil

3

1 reference

2 December 2017

M Jelínková

4

1 reference

2 December 2017

B Ríhová

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Journal of Controlled Release

2 December 2017

published in

1 reference

2 December 2017

volume

87

1 reference

2 December 2017

issue

1-3

1 reference

2 December 2017

page(s)

33-47

1 reference

Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Cis-aconityl spacer between daunomycin and macromolecular carriers: A model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Studies on the rate and control of antibody oxidation by periodate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

A colorimetric method for determining low concentrations of mercaptans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

Differences in the intracellular fate of free and polymer-bound doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900348-6

7 January 2021

10.1016/S0168-3659(02)00348-6

Identifiers

DOI

1 reference

2 December 2017

1 reference